Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas (Q44415304)

2 December 2017

title

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas (English)

1 reference

2 December 2017

1 reference

1 reference

27 December 2023

author name string

Michael Glantz

1

1 reference

2 December 2017

Marc Chamberlain

2

1 reference

2 December 2017

Qin Liu

3

1 reference

2 December 2017

N. Scott Litofsky

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12712481

27 December 2023

Lawrence D. Recht

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12712481

27 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.11323

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.11323

27 December 2023

1 reference

27 December 2023

1 reference

2 December 2017

volume

97

1 reference

2 December 2017

issue

9

1 reference

2 December 2017

page(s)

2262-2266

1 reference

The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III-IV gliomas

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

Malignant supratentorial glioma in the elderly: is radiotherapy useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Management of patients aged over 60 years with supratentorial glioma: lessons from an audit.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Age and clinical decision making in oncology patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Time Trends in Incidence of Brain and Central Nervous System Cancers in Connecticut

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Increasing annual incidence of primary malignant brain tumors in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Increasing incidence of primary malignant brain tumors: influence of diagnostic methods

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Incidence studies of primary and secondary intracranial tumors: a systematic review of their methodology and results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Differences between neurological and neurosurgical approaches in the management of malignant brain tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Indications for surgery in the management of gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Primary central nervous system lymphoma: age and performance status are more important than treatment modality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Intracranial astrocytoma in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Supratentorial malignant gliomas: risk patterns and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Efficacy of radiotherapy for malignant gliomas in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Treatment of malignant gliomas in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

Cancer in the elderly: why so badly treated?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11323

7 January 2021

A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy

18

1 reference

Increasing brain cancer rates in Canada

27 December 2023

21

1 reference

Therapy of adult malignant brain tumors: what have the clinical trials taught us?

27 December 2023

28

1 reference

27 December 2023

Identifiers

DOI

10.1002/CNCR.11323

1 reference

2 December 2017

1 reference